Skip to main content
. Author manuscript; available in PMC: 2022 Aug 9.
Published in final edited form as: Behav Pharmacol. 2019 Oct;30(7):555–565. doi: 10.1097/FBP.0000000000000492

Table 1.

Average number of days ( ± SEM) to reach stability criteria, and the average mean adjusted delay ( ± SEM) at stability and during the satiety challenge for all treatment groups

Groups Days to stability ( ± SEM) Average mean adjusted delay: stability ( ± SEM) Average mean adjusted delay: satiety challenge ( ± SEM)
Saline 42.36 ( ± 3.80) 12.07 ( ± 0.74)   9.66 ( ± 1.13)*
Cocaine 39.50 ( ± 0.38) 14.59 ( ± 1.55) 12.09 ( ± 1.58)*
3,4-Methylenedioxypyrovalerone 44.66 ( ± 1.57) 10.97 ( ± 1.30)   7.61 ( ± 1.17)*

No significant differences were detected either between groups in the days to reach stability, or in the mean adjusted delay values during stability between groups.

Significant differences were detected when comparing the mean adjusted delay during stability and the satiety challenge within a group.

*

P< 0.05 compared to mean adjusted delay during stability.